Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limb-girdle and Facioscapulohumeral Muscular Dystrophies”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Testing effectiveness (Phase 2)Study completedNCT00104078
What this trial is testing

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyFacioscapulohumeral Muscular DystrophyLimb-Girdle Muscular Dystrophy
Wyeth is now a wholly owned subsidiary of Pfizer 108
Not applicableStudy completedNCT02810028
What this trial is testing

Acceptance and Commitment Therapy for Muscle Disease

Who this might be right for
Muscle Diseases
King's College Hospital NHS Trust 155
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableLooking for participantsNCT06378203
What this trial is testing

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

Who this might be right for
Muscular DystrophiesLimb Girdle Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+1 more
IRCCS Eugenio Medea 10
Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8